Covered recipient · General Payments record
TRELLIS H BAKER
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$3,678.64
- Reported across 197 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $445.94 | 24 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $132.74 | 8 |
| Novo Nordisk AS | $67.32 | 4 |
| Abbott Laboratories | $44.95 | 2 |
| Amgen Inc. | $38.13 | 2 |
| Otsuka America Pharmaceutical, Inc. | $29.52 | 1 |
| Corium, Inc. | $28.63 | 1 |
| Lilly USA, LLC | $28.19 | 2 |
| Acerta Pharma LLC | $24.24 | 1 |
| DEXCOM, INC. | $18.67 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $18.53 | 1 |
| Hikma Pharmaceuticals USA | $15.02 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (24)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $22.15 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125297468 | CMS |
| Abbott Laboratories | $22.80 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125297470 | CMS |
| ABBVIE INC. | $18.52 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103269183 | CMS |
| ABBVIE INC. | $17.04 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103269185 | CMS |
| ABBVIE INC. | $20.31 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103269187 | CMS |
| ABBVIE INC. | $7.30 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103269189 | CMS |
| ABBVIE INC. | $15.24 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103269191 | CMS |
| ABBVIE INC. | $18.45 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103269193 | CMS |
| ABBVIE INC. | $15.74 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103269195 | CMS |
| ABBVIE INC. | $20.14 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103269197 | CMS |
| Amgen Inc. | $19.23 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115437468 | CMS |
| Amgen Inc. | $18.90 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115437472 | CMS |
| AstraZeneca Pharmaceuticals LP | $24.24 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104508576 | CMS |
| Corium, LLC | $28.63 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100198534 | CMS |
| Dexcom, Inc. | $18.67 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153341763 | CMS |
| Hikma Pharmaceuticals USA | $15.02 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127506821 | CMS |
| Lilly USA, LLC | $15.12 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135484673 | CMS |
| Lilly USA, LLC | $13.07 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135468245 | CMS |
| Novo Nordisk Inc | $15.50 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097482319 | CMS |
| Novo Nordisk Inc | $20.49 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097461304 | CMS |
| Novo Nordisk Inc | $17.27 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096590257 | CMS |
| Novo Nordisk Inc | $14.06 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096996743 | CMS |
| Otsuka America Pharmaceutical, Inc. | $29.52 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118857673 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $18.53 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153562986 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.